Use of OCs Containing Dienogest and Risk of Venous Thromboembolism.

Trial Profile

Use of OCs Containing Dienogest and Risk of Venous Thromboembolism.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Mar 2010

At a glance

  • Drugs Dienogest (Primary)
  • Indications Pregnancy
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Dec 2009 Actual number of patients changed from 681 to 3400 as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Actual number of patients added (681) as reported by ClinicalTrials.gov.
    • 05 Feb 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top